Shanghai Microport Medbot-h Stock price
Compare with Peer Group
Is Shanghai Microport Medbot-h a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,133 stocks worldwide.
Key metrics
Shanghai Microport Medbot-h Stock Analysis
Analyst Opinions
15 Analysts have issued a Shanghai Microport Medbot-h forecast:
Analyst Opinions
15 Analysts have issued a Shanghai Microport Medbot-h forecast:
Don't miss a Thing! We will send you all news about Shanghai Microport Medbot-h directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. The company is headquartered in Shanghai, Shanghai and currently employs 464 full-time employees. The company went IPO on 2021-11-02. The firm's business covers the fields of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The firm's products include Toumai LaparoscopicSurgical Robot, Toumai Single-port Laparoscopic Surgical Robot, DFVision Three Dimensions (3D) Electronic Laparoscope, SkyWalker Orthopedic Surgical Robot, Trans-bronchial Surgical Robot, R-ONE Vascular Interventional Robot, and iSR’obot Mona Lisa RoboticTransperineal Prostate Biopsy System. The firm conducts its businesses in domestic and overseas markets.
| Head office | China |
| Employees | 464 |
| Website | www.medbotsurgical.com |


